Drug Safety

Reflections on Attribution and Decisions in Pharmacovigilance

Ola Caster, I. Ralph Edwards

How to Apply the Human Factor to Periodic Safety Update Reports

Brian David Edwards, Giovanni Furlan

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

Gary Stiefel, Frank M.C. Besag

Proton Pump Inhibitors and Fracture Risk

Michael Bodmer, Christian Meier, Marius E. Kraenzlin, Christoph R. Meier

Nature, Occurrence and Consequences of Medication-Related Adverse Events During Hospitalization

Lilian H.F. Hoonhout, Martine C. de Bruijne, Cordula Wagner, Henk Asscheman, Gerrit van der Wal, Maurits W. van Tulder

Mapping the Safety Profile of Biologicals

Thijs J. Giezen, Aukje K. Mantel-Teeuwisse, Ronald H.B. Meyboom, Sabine M.J.M. Straus, Hubert G.M. Leufkens, Toine C.G. Egberts

Drug-Drug Interactions in Cardiac and Cardiothoracic Intensive Care Units

Pamela L. Smithburger, Sandra L. Kane-Gill, Amy L. Seybert

Pharmacovigilance Activities in Nepal

Subish Palaian, Mohamed Izham Mohamed Ibrahim, Pranaya Mishra, Kadir Alam, Pathiyil Ravi Shankar, Bhupendra Bahadur Thapa

International Society of Pharmacovigilance